|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/047 | |
| A61K 31/191 | |||
| A61K 31/352 | |||
| A61K 45/06 | |||
| A61P 17/02 | |||
| A61P 17/14 | |||
| A61P 17/06 | |||
| A61P 17/10 |
| (11) | Number of the document | 3355873 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16777760.6 |
| Date of filing the European patent application | 2016-09-29 | |
| (97) | Date of publication of the European application | 2018-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2016/053027 |
| Date | 2016-09-29 |
| (87) | Number | WO 2017/055846 |
| Date | 2017-04-06 |
| (30) | Number | Date | Country code |
| 201517215 | 2015-09-29 | GB |
| (72) |
B R , Tamįs, HU
STOTT, Colin, GB
DI MARZO, Vincenzo, GB
|
| (73) |
GW Pharma Limited,
Sovereign House Vision Park Chivers Way Histon, Cambridge, Cambridgeshire CB24 9BZ,
GB
|
| (54) | USE OF CANNABINOIDS IN THE TREATMENT OF INFLAMMATORY SKIN DISEASES |
| USE OF CANNABINOIDS IN THE TREATMENT OF INFLAMMATORY SKIN DISEASES |